• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂质体既能增强也能降低药物经皮渗透。

Liposomes can both enhance or reduce drugs penetration through the skin.

机构信息

Instituto de Investigación Médica M y M Ferreyra - CONICET- Universidad Nacional de Córdoba, Córdoba, Argentina.

UNITEFA - CONICET, Pharmaceutical Sciences Department, School of Chemistry, National University of Córdoba, Córdoba, Argentina.

出版信息

Sci Rep. 2018 Sep 5;8(1):13253. doi: 10.1038/s41598-018-31693-y.

DOI:10.1038/s41598-018-31693-y
PMID:30185887
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6125578/
Abstract

The adequate formulation of topical vehicles to treat skin diseases is particularly complex. A desirable formulation should enhance the accumulation of the active drugs in the target tissue (the skin), while avoiding the penetration enhancement to be so large that the drugs reach the systemic circulation in toxic amounts. We have evaluated the transcutaneous penetration of three drugs chosen for their widely variable physicochemical properties: Amphotericin B, Imiquimod and Indole. We incorporated the drugs in fluid or ultra-flexible liposomes. Ultra-flexible liposomes produced enhancement of drug penetration into/through human skin in all cases in comparison with fluid liposomes without detergent, regardless of drug molecular weight. At the same time, our results indicate that liposomes can impede the transcutaneous penetration of molecules, in particular small ones.

摘要

治疗皮肤病的局部药物制剂的配方特别复杂。理想的制剂应促进活性药物在靶组织(皮肤)中的积累,同时避免渗透增强过大,以致药物以有毒量到达全身循环。我们评估了三种药物的经皮渗透,这些药物因其广泛的物理化学性质而被选择:两性霉素 B、咪喹莫特和吲哚。我们将药物包裹在流体或超柔软脂质体中。与不含去污剂的流体脂质体相比,超柔软脂质体在所有情况下都能增强药物渗透进入/穿过人体皮肤,而与药物分子量无关。同时,我们的结果表明脂质体可以阻碍分子,特别是小分子的经皮渗透。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc16/6125578/eb97ee63ad9d/41598_2018_31693_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc16/6125578/08af5bbbbde6/41598_2018_31693_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc16/6125578/20fdb4d4d356/41598_2018_31693_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc16/6125578/c4da20068d31/41598_2018_31693_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc16/6125578/94b4f059b04c/41598_2018_31693_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc16/6125578/ad64e1ddd781/41598_2018_31693_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc16/6125578/b7a31bfbf9b5/41598_2018_31693_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc16/6125578/eb97ee63ad9d/41598_2018_31693_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc16/6125578/08af5bbbbde6/41598_2018_31693_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc16/6125578/20fdb4d4d356/41598_2018_31693_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc16/6125578/c4da20068d31/41598_2018_31693_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc16/6125578/94b4f059b04c/41598_2018_31693_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc16/6125578/ad64e1ddd781/41598_2018_31693_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc16/6125578/b7a31bfbf9b5/41598_2018_31693_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc16/6125578/eb97ee63ad9d/41598_2018_31693_Fig7_HTML.jpg

相似文献

1
Liposomes can both enhance or reduce drugs penetration through the skin.脂质体既能增强也能降低药物经皮渗透。
Sci Rep. 2018 Sep 5;8(1):13253. doi: 10.1038/s41598-018-31693-y.
2
Design of Chitosan Nanocapsules with Compritol 888 ATO® for Imiquimod Transdermal Administration. Evaluation of Their Skin Absorption by Raman Microscopy.壳聚糖纳米胶囊的设计 Compritol 888 ATO® 用于咪喹莫特经皮给药。拉曼显微镜评估其皮肤吸收。
Pharm Res. 2020 Sep 17;37(10):195. doi: 10.1007/s11095-020-02925-6.
3
Enhanced stability and permeation potential of nanoemulsion containing sefsol-218 oil for topical delivery of amphotericin B.含Sefsol-218油的纳米乳剂用于两性霉素B局部给药时增强的稳定性和渗透潜力。
Drug Dev Ind Pharm. 2015 May;41(5):780-90. doi: 10.3109/03639045.2014.902957. Epub 2014 Mar 24.
4
Topical amphotericin B in ultradeformable liposomes: Formulation, skin penetration study, antifungal and antileishmanial activity in vitro.超可变形脂质体中的局部用两性霉素B:制剂、皮肤渗透研究、体外抗真菌和抗利什曼原虫活性
Colloids Surf B Biointerfaces. 2016 Mar 1;139:190-8. doi: 10.1016/j.colsurfb.2015.12.003. Epub 2015 Dec 3.
5
Amphotericin B-loaded nanocarriers for topical treatment of cutaneous leishmaniasis: development, characterization, and in vitro skin permeation studies.载两性霉素 B 的纳米载体用于皮肤利什曼病的局部治疗:开发、表征和体外皮肤渗透研究。
J Biomed Nanotechnol. 2012 Apr;8(2):322-9. doi: 10.1166/jbn.2012.1385.
6
Stability and transdermal absorption of topical amphotericin B liposome formulations.局部用两性霉素B脂质体制剂的稳定性和透皮吸收
Int J Pharm. 2004 Feb 11;270(1-2):279-86. doi: 10.1016/j.ijpharm.2003.10.031.
7
Design, Development, and Characterization of Imiquimod-Loaded Chitosan Films for Topical Delivery.咪喹莫特负载壳聚糖膜的设计、制备与表征及其经皮给药系统
AAPS PharmSciTech. 2019 Jan 8;20(2):58. doi: 10.1208/s12249-018-1288-5.
8
Calcipotriol delivery into the skin with PEGylated liposomes.用聚乙二醇化脂质体将钙泊三醇递送至皮肤中。
Eur J Pharm Biopharm. 2012 Aug;81(3):532-9. doi: 10.1016/j.ejpb.2012.04.005. Epub 2012 Apr 19.
9
Toxicity, stability and pharmacokinetics of amphotericin B in immunomodulator tuftsin-bearing liposomes in a murine model.两性霉素B负载免疫调节剂促吞噬肽脂质体在小鼠模型中的毒性、稳定性及药代动力学
J Antimicrob Chemother. 2006 Jul;58(1):125-32. doi: 10.1093/jac/dkl177. Epub 2006 May 18.
10
Nanocarrier-based topical drug delivery for an antifungal drug.基于纳米载体的局部药物递送系统用于一种抗真菌药物。
Drug Dev Ind Pharm. 2014 Apr;40(4):527-41. doi: 10.3109/03639045.2013.771647. Epub 2013 Apr 29.

引用本文的文献

1
Insights into Liposomal and Gel-Based Formulations for Dermatological Treatments.皮肤治疗用脂质体和凝胶制剂的见解
Gels. 2025 Mar 26;11(4):245. doi: 10.3390/gels11040245.
2
Are We Ready to Measure Skin Permeation of Modern Antiaging GHK-Cu Tripeptide Encapsulated in Liposomes?我们准备好测量脂质体包裹的现代抗衰GHK-Cu三肽的皮肤渗透性了吗?
Molecules. 2025 Jan 1;30(1):136. doi: 10.3390/molecules30010136.
3
Enhancement of Physical Appearance, Skin Permeation, and Odor Reduction Using Liposome of Hydrolyzed Salmon Collagen for Cosmetic Products.

本文引用的文献

1
In vitro stabilization and in vivo improvement of ocular pharmacokinetics of the multi-therapeutic agent baicalin: Delineating the most suitable vesicular systems.黄芩苷多治疗药物的体外稳定性和体内眼药代动力学的改善:确定最合适的囊泡系统。
Int J Pharm. 2018 Mar 25;539(1-2):83-94. doi: 10.1016/j.ijpharm.2018.01.041. Epub 2018 Jan 31.
2
Mechanisms of imiquimod skin penetration.咪喹莫特的皮肤渗透机制。
Int J Pharm. 2016 Sep 10;511(1):516-523. doi: 10.1016/j.ijpharm.2016.07.043. Epub 2016 Jul 21.
3
Drug permeation and barrier damage in Leishmania-infected mouse skin.
使用水解鲑鱼胶原蛋白脂质体提升化妆品的外观、皮肤渗透性并减少异味
Scientifica (Cairo). 2024 Apr 24;2024:7843660. doi: 10.1155/2024/7843660. eCollection 2024.
4
Topical drug delivery strategies for enhancing drug effectiveness by skin barriers, drug delivery systems and individualized dosing.通过皮肤屏障、药物递送系统和个体化给药来提高药物疗效的局部给药策略。
Front Pharmacol. 2024 Jan 16;14:1333986. doi: 10.3389/fphar.2023.1333986. eCollection 2023.
5
Effects of Dietary Components on Mast Cells: Possible Use as Nutraceuticals for Allergies?膳食成分对肥大细胞的影响:作为变应原的营养疗法?
Cells. 2023 Nov 10;12(22):2602. doi: 10.3390/cells12222602.
6
Rational Design of Topical Semi-Solid Dosage Forms-How Far Are We?局部用半固体制剂的合理设计——我们进展到什么程度了?
Pharmaceutics. 2023 Jun 26;15(7):1822. doi: 10.3390/pharmaceutics15071822.
7
Simultaneous control of infection and inflammation with keratin-derived antibacterial peptides targeting TLRs and co-receptors.同时利用靶向 TLRs 和共受体的角蛋白来源抗菌肽来控制感染和炎症。
Sci Transl Med. 2023 Mar 8;15(686):eade2909. doi: 10.1126/scitranslmed.ade2909.
8
Current Advances in Lipid Nanosystems Intended for Topical and Transdermal Drug Delivery Applications.用于局部和透皮给药应用的脂质纳米系统的当前进展
Pharmaceutics. 2023 Feb 15;15(2):656. doi: 10.3390/pharmaceutics15020656.
9
Liposomal Amphotericin B for Treatment of Leishmaniasis: From the Identification of Critical Physicochemical Attributes to the Design of Effective Topical and Oral Formulations.脂质体两性霉素B治疗利什曼病:从关键物理化学特性的鉴定到有效局部和口服制剂的设计
Pharmaceutics. 2022 Dec 28;15(1):99. doi: 10.3390/pharmaceutics15010099.
10
Tocotrienol in the Treatment of Topical Wounds: Recent Updates.生育三烯酚在局部伤口治疗中的应用:最新进展
Pharmaceutics. 2022 Nov 16;14(11):2479. doi: 10.3390/pharmaceutics14112479.
利什曼原虫感染小鼠皮肤中的药物渗透和屏障损伤。
J Antimicrob Chemother. 2016 Jun;71(6):1578-85. doi: 10.1093/jac/dkw012. Epub 2016 Feb 21.
4
Topical amphotericin B in ultradeformable liposomes: Formulation, skin penetration study, antifungal and antileishmanial activity in vitro.超可变形脂质体中的局部用两性霉素B:制剂、皮肤渗透研究、体外抗真菌和抗利什曼原虫活性
Colloids Surf B Biointerfaces. 2016 Mar 1;139:190-8. doi: 10.1016/j.colsurfb.2015.12.003. Epub 2015 Dec 3.
5
Ultradeformable liposomes as multidrug carrier of resveratrol and 5-fluorouracil for their topical delivery.超可变形脂质体作为白藜芦醇和5-氟尿嘧啶的多药载体用于局部给药。
Int J Pharm. 2015 Jul 15;489(1-2):1-10. doi: 10.1016/j.ijpharm.2015.04.056. Epub 2015 Apr 18.
6
Investigation of the mechanism of enhanced skin penetration by ultradeformable liposomes.超变形脂质体增强皮肤渗透机制的研究。
Int J Nanomedicine. 2014 Jul 25;9:3539-50. doi: 10.2147/IJN.S65287. eCollection 2014.
7
Structural features of ultradeformable archaeosomes for topical delivery of ovalbumin.用于卵清蛋白局部递送的超可变形古脂质体的结构特征
Colloids Surf B Biointerfaces. 2014 Sep 1;121:281-9. doi: 10.1016/j.colsurfb.2014.05.015. Epub 2014 May 22.
8
Development and characterization of a novel controlled release drug delivery system based on nanostructured lipid carriers gel for meloxicam.基于载药纳米结构脂质载体凝胶的美洛昔康新型控释给药系统的研制与评价。
Life Sci. 2013 Nov 13;93(21):763-72. doi: 10.1016/j.lfs.2013.09.027. Epub 2013 Oct 7.
9
Spatially resolved two-color diffusion measurements in human skin applied to transdermal liposome penetration.用于经皮脂质体渗透的人体皮肤中空间分辨双色扩散测量。
J Invest Dermatol. 2013 May;133(5):1260-8. doi: 10.1038/jid.2012.461. Epub 2012 Dec 6.
10
Elastic vesicles for transdermal drug delivery of hydrophilic drugs: a comparison of important physicochemical characteristics of different vesicle types.弹性囊泡用于亲水性药物的经皮给药:不同囊泡类型的重要物理化学特性比较。
J Biomed Nanotechnol. 2012 Aug;8(4):613-23. doi: 10.1166/jbn.2012.1426.